Aurora Cannabis Inc., Canada’s leading medical cannabis company, has launched its premium products in the New Zealand market. This marks a significant milestone in medical cannabis accessibility in New Zealand, which is an emerging market with substantial growth potential.
Product Launch
Aurora's initial product portfolio includes premium dried flowers meticulously bred and cultivated to address various patient needs. These offerings highlight Aurora's commitment to quality, potency, and therapeutic benefits. The first product, Equiposa, is a balanced dried cannabis product designed to provide diverse options for patient care.
CEO’s Statement
"As a global leader in medical cannabis, Aurora is proud to be at the forefront of advancing patient access in New Zealand with this first and meaningful product launch," said Miguel Martin, CEO of Aurora.
"We are thrilled to offer prescribers and patients premium dried flower options that embody our dedication to opening the world to cannabis while prioritizing patient care and well-being. We see great potential in the New Zealand market and intend to leverage symmetry with our leadership in Australia."
